1. Adams, C.W.M., Abdulla, Y.H., Tomes, E.M., and Poston, R.N., 1987, Periventricular lesions in multiple sclerosis: their perivenous origin and relationship to granular ependymitis, Neuropath. Appl. Neurobiol. 13: 141.
2. Aggarwal, B.B., Kohr, W.J., Hass, P.E., Moffat, B., Spencer, S.A., Henzel, W.J., Bringman, T.S., Nedwin, G.E., Goeddel, D.V. and Harkins, R.N., 1985, Human tumor necrosis factor: production, purification, and characterization, J. Biol. Chem. 260: 2345.
3. Bailey, S.J., Featherstone, R.L., Jordan, C.C. and Morton, I.K.M., 1986, An examination of the pharmacology of two substance P antagonists and the evidence for tachykinin receptor subtypes, Brit. J. Pharmacol. 87: 79.
4. Bar-Shavit, Z., Goldman. R., Stabinski, Y., Gottlieb, P., Fridkin, M., Teichberg, V.I., and Blumberg, S., 1980, Enhancement of phagocytosis - a newly found activity of substance P residing in its N-terminal tetrapeptide sequence, J. Immunol. 130: 89.
5. Beaujouan, J.C., Torrens, Y., Saffroy, M., and Glowinski, J., 1986, Quantitative autoradiographic analysis of the distribution of binding sites for 125E Bolton Hunter derivatives of eledoisin and substance P in the rat brain, Neurosci. 18: 857.